Cart
sales@molnova.com
PF-04745637
CAS No. 1917294-46-2
PF-04745637( —— )
Catalog No. M26002 CAS No. 1917294-46-2
PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 158 | In Stock |
|
| 5MG | 141 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 333 | In Stock |
|
| 50MG | 465 | In Stock |
|
| 100MG | 642 | In Stock |
|
| 200MG | 863 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-04745637
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.
-
DescriptionPF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.(In Vivo):PF-04745637 (topically applied; 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin.
-
In Vitro——
-
In VivoTopically applied PF-04745637 (Compound 8; 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorImmunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1917294-46-2
-
Formula Weight509.01
-
Molecular FormulaC27H32ClF3N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (245.58 mM)
-
SMILESOC1(CCN(CC1)C(CNC(=O)C1(CCCC1)c1ccc(Cl)cc1)Cc1ccccc1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Constituents of Compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers.Cancer Lett., 2002, 177(1):7-12.
molnova catalog
related products
-
Pinokalant
Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region.
-
EIPA
EIPA (L593754, MH 12-43) is a TRPP3 channel inhibitor (IC50: 10.5 μM). It also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.It is found that EIPA, benzamil, and phenamil rapidly and reversibly block Ca2+-activated TRPP3 channel activation at -50 mV, with IC50s of 143, 10.5, 1.1, and 0.14 μM, respectively.
-
TRPA1-IN-2
TRPA1-IN-2 is a potent and orally active TRPA1 inhibitor with an IC50 value of 0.04 μM.TRPA1-IN-2 has anti-inflammatory activity.
